| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.62 | 0.009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |